{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:08:09Z","timestamp":1780085289835,"version":"3.54.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T00:00:00Z","timestamp":1577491200000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DA045884-01"],"award-info":[{"award-number":["DA045884-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DA046487-01"],"award-info":[{"award-number":["DA046487-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AA026949-01"],"award-info":[{"award-number":["AA026949-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["W81XWH-17-1-0256"],"award-info":[{"award-number":["W81XWH-17-1-0256"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Clinical Pharmacology"},{"name":"St. Louis College of Pharmacy and Washington University to SM"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32 GM08294"],"award-info":[{"award-number":["T32 GM08294"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1171245- 309-PADPO"],"award-info":[{"award-number":["1171245- 309-PADPO"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH\/NCI Cancer Center","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA06241"],"award-info":[{"award-number":["DA06241"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA07242"],"award-info":[{"award-number":["DA07242"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mayday Foundation"},{"name":"National Institute of Mental Health's Psychoactive Drug Screening Program","award":["# HHSN-271-2018-00023-C"],"award-info":[{"award-number":["# HHSN-271-2018-00023-C"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejmech.2018.12.048","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T22:27:52Z","timestamp":1545431272000},"page":"241-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Synthesis of spiro-2,6-dioxopiperazine and spiro-2,6-dioxopyrazine scaffolds using amino acids in a three-component reaction to generate potential Sigma-1 (\u03c31) receptor selective ligands"],"prefix":"10.1016","volume":"164","author":[{"given":"Rajendra","family":"Uprety","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"V\u00e1radi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Allaoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel N.","family":"Redel-Traub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis C.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan N.","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex C.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay S.","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavril W.","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2931-3823","authenticated-orcid":false,"given":"Susruta","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.12.048_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/ROC.S65115","article-title":"Recent advances in the discovery and design of multicomponent reactions for the generation of small-molecule libraries","volume":"5","author":"Malinakova","year":"2015","journal-title":"Rep. Org. Chem."},{"key":"10.1016\/j.ejmech.2018.12.048_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1126\/science.1089946","article-title":"Generating diverse skeletons of small molecules combinatorially","volume":"302","author":"Burke","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.12.048_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/0929867033368600","article-title":"Multi-component reactions : emerging chemistry in drug discovery\" 'from xylocain to crixivan","volume":"10","author":"Hulme","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.048_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cbpa.2008.02.004","article-title":"Isocyanide-based multicomponent reactions in drug discovery","volume":"12","author":"Akritopoulou-Zanze","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.12.048_bib5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1039\/c2md20089a","article-title":"Recent applications of multicomponent reactions in medicinal chemistry","volume":"3","author":"Slobbe","year":"2012","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2018.12.048_bib6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1747-0285.2011.01288.x","article-title":"MCR synthesis of praziquantel derivatives","volume":"79","author":"Liu","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2018.12.048_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/ar700109k","article-title":"Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection","volume":"41","author":"Njoroge","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.12.048_bib8","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1039\/c2sc20669b","article-title":"A\u00a0chemical synthesis of 11-methoxy mitragynine pseudoindoxyl featuring the interrupted Ugi reaction","volume":"3","author":"Kim","year":"2012","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2018.12.048_bib9","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1021\/acs.jmedchem.6b00748","article-title":"Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit beta-arrestin-2","volume":"59","author":"Varadi","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2018.12.048_bib10","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1021\/acschemneuro.5b00137","article-title":"Synthesis of carfentanil amide opioids using the Ugi multicomponent reaction","volume":"6","author":"V\u00e1radi","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2018.12.048_bib11","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U","article-title":"Multicomponent reactions with isocyanides","volume":"39","author":"D\u00f6mling","year":"2000","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2018.12.048_bib12","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1021\/cr100233r","article-title":"Chemistry and biology of multicomponent reactions","volume":"112","author":"D\u00f6mling","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.12.048_bib13","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1002\/anie.201006515","article-title":"Multicomponent reaction design in the quest for molecular complexity and diversity","volume":"50","author":"Ruijter","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2018.12.048_bib14","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3390\/molecules21010019","article-title":"Isocyanide-based multicomponent reactions for the synthesis of heterocycles","volume":"21","author":"Varadi","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.12.048_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/80100053","article-title":"The chemistry of isocyanides, their MultiComponent reactions and their libraries","volume":"8","author":"Ugi","year":"2003","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.12.048_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/tcr.201500201","article-title":"Multicomponent reactions, union of MCRs and beyond","volume":"15","author":"Zarganes-Tzitzikas","year":"2015","journal-title":"Chem. Rec."},{"key":"10.1016\/j.ejmech.2018.12.048_bib17","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.tetlet.2017.02.021","article-title":"Ugi three-component reaction of alcohols, amines and isocyanides: a new approach to the synthesis of cyclic amidines","volume":"58","author":"Dev","year":"2017","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.12.048_bib18","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1021\/jo2021967","article-title":"An asymmetric Ugi three-component reaction induced by chiral cyclic imines: synthesis of morpholin\u2013 or piperazine\u2013keto-carboxamide derivatives","volume":"77","author":"Zhu","year":"2012","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.12.048_bib19","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1021\/ol500328t","article-title":"Three-component coupling approach for the synthesis of diverse heterocycles utilizing reactive nitrilium trapping","volume":"16","author":"Varadi","year":"2014","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.12.048_bib20","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1021\/cr200398y","article-title":"2,5-Diketopiperazines: synthesis, reactions, medicinal chemistry, and bioactive natural products","volume":"112","author":"Borthwick","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.12.048_bib21","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.3390\/md12126213","article-title":"An update on 2,5-diketopiperazines from marine organisms","volume":"12","author":"Huang","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2018.12.048_bib22","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1021\/jm7013056","article-title":"Spiro[(dihydropyrazin-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-di one)]-based cytotoxic agents: structure-activity relationship studies on the substituent at N4-position of the diketopiperazine domain","volume":"51","author":"Gomez-Monterrey","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.048_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejmech.2014.06.030","article-title":"Design and synthesis of novel soluble 2,5-diketopiperazine derivatives as potential anticancer agents","volume":"83","author":"Liao","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.048_bib24","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1081\/NCN-200040614","article-title":"Synthesis and antiviral properties of arabino and ribonucleosides of 1,3-dideazaadenine, 4-nitro-1,3-dideazapurine and diketopiperazine","volume":"23","author":"Sinha","year":"2004","journal-title":"Nucleos. Nucleot. Nucl."},{"key":"10.1016\/j.ejmech.2018.12.048_bib25","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.1021\/jm049940a","article-title":"Structure-based exploration of cyclic dipeptide chitinase inhibitors","volume":"47","author":"Houston","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.048_bib26","doi-asserted-by":"crossref","first-page":"25369","DOI":"10.1074\/jbc.271.41.25369","article-title":"The antibiotic bicyclomycin affects the secondary RNA binding site of Escherichia coli transcription termination factor Rho","volume":"271","author":"Magyar","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.12.048_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1134\/S0006297918020074","article-title":"2,5-Diketopiperazines: a new class of poly(ADP-ribose)polymerase inhibitors","volume":"83","author":"Nilov","year":"2018","journal-title":"Biochemistry. Biokhimiia"},{"key":"10.1016\/j.ejmech.2018.12.048_bib28","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2174\/1573406413666170425165659","article-title":"Synthesis of new arylidene 2,5-diketopiperazines and evaluation of their anti-acetylcholinesterase, anti-xanthine oxidase, anti-diabetic and cytotoxic activities","volume":"13","author":"Belkacem","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.048_bib29","doi-asserted-by":"crossref","first-page":"9923","DOI":"10.1016\/j.tet.2007.04.105","article-title":"Diketopiperazines: biological activity and synthesis","volume":"63","author":"Martins-Teixeira","year":"2007","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.12.048_bib30","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1021\/jo050146m","article-title":"Molecular diversity via amino acid derived alpha-amino nitriles: synthesis of spirocyclic 2,6-dioxopiperazine derivatives","volume":"70","author":"Gonzalez-Vera","year":"2005","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.12.048_bib31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cbdd.13088","article-title":"Lipophilic conformationally constrained spiro carbocyclic 2,6-diketopiperazine-1-acetohydroxamic acid analogues as trypanocidal and leishmanicidal agents: an extended SAR study","volume":"91","author":"Zoidis","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2018.12.048_bib32","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1016\/j.tet.2008.05.005","article-title":"A\u00a0facile and effective synthesis of lipophilic 2,6-diketopiperazine analogues","volume":"64","author":"Fytas","year":"2008","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.12.048_bib33","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ja.2010.86","article-title":"Coelomycin, a highly substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus aureus fitness test profiling","volume":"63","author":"Goetz","year":"2010","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2018.12.048_bib34","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1021\/acs.orglett.5b00887","article-title":"Multicomponent cascade reactions of unprotected carbohydrates and amino acids","volume":"17","author":"Voigt","year":"2015","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.12.048_bib35","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1021\/ol302379a","article-title":"\u201cExtreme\u201d Ugi reactions with some complex \u03b1-amino acids","volume":"14","author":"Turner","year":"2012","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.12.048_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/mol.115.101170","article-title":"Biochemical Pharmacology of the sigma-1 receptor","volume":"89","author":"Chu","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2018.12.048_bib37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2010.08.007","article-title":"The sigma-1 receptor chaperone as an inter-organelle signaling modulator","volume":"31","author":"Su","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2018.12.048_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ejmech.2018.02.024","article-title":"Investigating isoindoline, tetrahydroisoquinoline, and tetrahydrobenzazepine scaffolds for their sigma receptor binding properties","volume":"151","author":"Linkens","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1-3","key":"10.1016\/j.ejmech.2018.12.048_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2013.01.068","article-title":"Sigma 1 receptor: a new therapeutic target for pain","volume":"716","author":"Zamanillo","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.12.048_bib40","first-page":"235970","article-title":"Potential molecular mechanisms on the role of the sigma-1 receptor in the action of cocaine and methamphetamine","volume":"5","author":"Yasui","year":"2016","journal-title":"J.\u00a0Drug Alcohol Res."},{"key":"10.1016\/j.ejmech.2018.12.048_bib41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of sigma(1) receptor ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2018.12.048_bib42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature17391","article-title":"Crystal structure of the human \u03c31 receptor","volume":"532","author":"Schmidt","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.12.048_bib43","doi-asserted-by":"crossref","first-page":"10280","DOI":"10.1002\/anie.201205366","article-title":"Efficient assembly of iminodicarboxamides by a \"truly\" four-component reaction","volume":"51","author":"Khoury","year":"2012","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2018.12.048_bib44","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1039\/C6CS00825A","article-title":"New development in the enantioselective synthesis of spiro compounds","volume":"47","author":"Ding","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2018.12.048_bib45","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.2174\/0929867325666180309124821","article-title":"Advances in spirocyclic hybrids: chemistry and medicinal actions","volume":"25","author":"Benabdallah","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.048_bib46","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1080\/00397911.2016.1211704","article-title":"Review of synthesis and various biological activities of spiro heterocyclic compounds comprising oxindole and pyrrolidine moities","volume":"46","author":"Saraswat","year":"2016","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2018.12.048_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/jpet.114.216671","article-title":"Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418","volume":"351","author":"Lever","year":"2014","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2018.12.048_bib48","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1021\/jm00038a002","article-title":"Synthesis and characterization of [125I](N-benzylpiperidin-4-yl)4-iodobenzamide, 4-IBP, a new sigma receptor radiopharmaceutical: high affinity binding to MCF-7 breast tumor cells","volume":"37","author":"John","year":"1994","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.048_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cell.2017.12.011","article-title":"Structure of the nanobody-stabilized active state of the kappa opioid receptor","volume":"172","author":"Che","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2018.12.048_bib50","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.euroneuro.2011.08.002","article-title":"Evaluation of sigma (s) receptors in the antidepressant-like effects of ketamine in\u00a0vitro and in\u00a0vivo","volume":"22","author":"Robson","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2018.12.048_bib51","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2174\/138161212799436601","article-title":"Sigma-1 receptors: potential targets for the treatment of substance abuse","volume":"18","author":"Robson","year":"2012","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2018.12.048_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jphs.2014.12.005","article-title":"Role of sigma-1 receptors in neurodegenerative diseases","volume":"127","author":"Nguyen","year":"2015","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2018.12.048_bib53","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1038\/s41598-018-22217-9","article-title":"Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice","volume":"8","author":"Castany","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2018.12.048_bib54","series-title":"APEX2 (Version 2013.12)","article-title":"Program for bruker CCD X-ray diffractometer control","year":"2013"},{"key":"10.1016\/j.ejmech.2018.12.048_bib55","series-title":"SHELXTL, Version 6.14","article-title":"Program for solution and refinement of crystal structures","author":"Sheldrick","year":"2009"},{"key":"10.1016\/j.ejmech.2018.12.048_bib56","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide:\u2009 a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.048_bib57","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide:\u2009 a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418310857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418310857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:49:25Z","timestamp":1759326565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418310857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":57,"alternative-id":["S0223523418310857"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.12.048","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of spiro-2,6-dioxopiperazine and spiro-2,6-dioxopyrazine scaffolds using amino acids in a three-component reaction to generate potential Sigma-1 (\u03c31) receptor selective ligands","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.12.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}